Chemoinformaics analysis of Trans-5,6-Lutein-Epoxide
| Molecular Weight | 584.885 | nRot | 10 |
| Heavy Atom Molecular Weight | 528.437 | nRig | 23 |
| Exact Molecular Weight | 584.423 | nRing | 3 |
| Solubility: LogS | -6.432 | nHRing | 1 |
| Solubility: LogP | 8.491 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 99 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 43 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 56 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 40 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 106.546 |
| nHD | 2 | BPOL | 57.9156 |
| QED | 0.153 |
| Synth | 5.39 |
| Natural Product Likeliness | 2.358 |
| NR-PPAR-gamma | 0.013 |
| Lipinski | Rejected |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 1 |
| Pgp-sub | 0.915 |
| HIA | 0.591 |
| CACO-2 | -5.104 |
| MDCK | 0.0000216 |
| BBB | 0.027 |
| PPB | 0.980388 |
| VDSS | 3.199 |
| FU | 0.0266561 |
| CYP1A2-inh | 0.011 |
| CYP1A2-sub | 0.29 |
| CYP2c19-inh | 0.155 |
| CYP2c19-sub | 0.958 |
| CYP2c9-inh | 0.284 |
| CYP2c9-sub | 0.183 |
| CYP2d6-inh | 0.141 |
| CYP2d6-sub | 0.948 |
| CYP3a4-inh | 0.36 |
| CYP3a4-sub | 0.94 |
| CL | 2.032 |
| T12 | 0.135 |
| hERG | 0.581 |
| Ames | 0.353 |
| ROA | 0.268 |
| SkinSen | 0.97 |
| Carcinogencity | 0.536 |
| EI | 0.017 |
| Respiratory | 0.396 |
| NR-Aromatase | 0.913 |
| Antiviral | Yes |
| Prediction | 0.63379 |